Beckman Coulter Life Sciences has introduced the DxFLEX, Europe’s first CE/IVD-marked 13-colour clinical flow cytometry system. The DxFLEX uses avalanche photodiode (APD) technology, which creates a highly sensitive semiconductor electronic device able to convert light to electricity. This addresses the limitations of traditional photomultiplier tube (PMT)-based flow cytometers. The use of APD technology transforms the way a compact flow cytometry instrument can deliver high-content research analysis.
compact flow cytometry instrument can deliver high-content research analysis.
“The DxFLEX flow cytometer opens up the possibilities for large hospitals and
commercial laboratories looking to expand their high-content analysis work with a
compact, easy-to-use system,” said Dr Mario Koksch (Beckman Coulter Life Sciences).
The APD technology in the DxFLEX reduces compensation spillover compared to
PMT-based cytometers, delivering greater confidence in results, streamlining the
laboratory’s workflow and reducing manual steps.
“The biggest challenge for user-defined testing, particularly when using 10 or more
fluorescence parameters, is the compensation process and the burden it places on staff.
Incorrect compensation is one of the main reasons for false results when running
multicolour flow cytometry panels, explained Dr Koksch.
T: +49 2151 333 0 E: [email protected] W: www.beckman.com